Neurologia
Guia prático de tratamento da síndrome de Dravet com anticonvulsivantes.
28 Abr, 2022 | 11:42hA Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication – CNS Drugs
Estudo de coorte | Associação de pressão arterial cumulativa com declínio cognitivo, demência e mortalidade.
27 Abr, 2022 | 15:29hMedicamentos anticolinérgicos e demência: deveríamos nos preocupar?
27 Abr, 2022 | 15:21hCommonly-prescribed drugs and dementia: should we be worried? – Evidently Cochrane
Revisão original: Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library
Conteúdos relacionados:
How well do you know your anticholinergic (antimuscarinic) drugs? – Therapeutics Initiative
Anticholinergic drugs and risk of dementia: case-control study – The BMJ
Comentário no Twitter
Commonly-prescribed drugs & dementia: should we be worried? https://t.co/pvWxT6q48Z A @CochraneUK blog: Jodi Watt (a researcher @UofGlasgow) explores the @CochraneDCIG evidence on whether #anticholinergics might increase people’s risk of future memory problems, or even #dementia
— The Cochrane Library (@CochraneLibrary) April 22, 2022
Estudo de coorte | Avaliação do escore de probabilidade do plasma amiloide para estimar os achados de tomografia por emissão de pósitrons (PET-CT) entre adultos com comprometimento cognitivo.
27 Abr, 2022 | 15:14h
Comentário no Twitter
This cohort study found a mass spectrometry-based blood test, measuring plasma Aβ42/40 & ApoE + age, accurately estimated brain amyloidosis via PET, and may help clinicians diagnose Alzheimer disease in patients with symptoms of cognitive impairment. https://t.co/VN7v0qf2uX
— JAMA Network Open (@JAMANetworkOpen) April 21, 2022
Estudo de coorte | Associação das experiências adversas na infância com o desenvolvimento de esclerose múltipla.
27 Abr, 2022 | 15:07hComunicado de imprensa: Childhood emotional trauma linked to heightened MS risk among women – BMJ Newsroom
Regulador de medicamentos do Reino Unido aconselha pacientes e médicos contra o uso de pregabalina durante a gestação em virtude de um possível risco aumentado de malformações congênitas.
25 Abr, 2022 | 12:40hVer também: Pregabalin and risks in pregnancy – Medicines and Healthcare products Regulatory Agency
Fonte: Avoid prescribing pregabalin during pregnancy if possible, says UK drug regulator – The BMJ ($)
Comentário no Twitter
The Medicines and Healthcare Products Regulatory Agency (@MHRAgovuk) has strengthened its warning about avoiding pregabalin during pregnancy after new data showed an increased risk of major congenital malformations associated with the drug https://t.co/ghGvqCqA0C
— The BMJ (@bmj_latest) April 22, 2022
Idade sugerida pela retina como um biomarcador preditivo de risco de doença de Parkinson no futuro.
25 Abr, 2022 | 12:19hRetinal age gap as a predictive biomarker of future risk of Parkinson’s disease – Age and Ageing
Conteúdo relacionado: Retinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link para o resumo – $ para o texto completo)
M-A | Associação entre imunoterápicos para o tratamento do câncer e eventos adversos neurológicos.
21 Abr, 2022 | 12:15hComentário convidado: Neurological Toxic Effects Associated With Treatment With Immune Checkpoint Inhibitors—Are We Really Safer Now? – JAMA Network Open
Conteúdos relacionados:
Autoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: Systematic Review – Neurology (link para o resumo – $ para o texto completo)
Comentário no Twitter
Meta-analysis of 39 RCTs found immune checkpoint inhibitors have lower risk of neurological adverse effects compared to cytotoxic chemotherapy, but higher than placebo, across a range of malignancies. https://t.co/02GhICcu5H
— JAMA Network Open (@JAMANetworkOpen) April 19, 2022
Estudo de coorte | Associação de queixas subjetivas de memória e focos de hiperintensidade na substância branca com declínio cognitivo entre idosos.
21 Abr, 2022 | 12:03hComentário: Memory complaints associated with structural brain abnormalities and increased dementia risk – HealthImaging
Comentário no Twitter
In this cohort study, subjective memory complaints (SMCs) were associated with larger white matter hyperintensity volumes and faster cognitive decline, suggesting that SMCs are an important sign of cognitive impairment. https://t.co/mpCXDbylnf
— JAMA Network Open (@JAMANetworkOpen) April 15, 2022
Vídeo | Isso é o que se sabe sobre o impacto da COVID-19 no cérebro.
21 Abr, 2022 | 11:41hHere’s what we know about COVID-19’s impact on the brain – Science
Conteúdos relacionados:
SARS-CoV-2 is associated with changes in brain structure in UK Biobank – Nature
Nervous system consequences of COVID-19 – Science
The COVID generation: how is the pandemic affecting kids’ brains? – Nature
Assessment of Cognitive Function in Patients After COVID-19 Infection – JAMA Network Open